Nature Biotechnology features the explosion of Chinese biotech

China is the “Innovation Nation” and “The next biotech superpower”, according to the November issue of Nature Biotechnology. Beijing is “set to challenge the pre-eminence of the US drug market. If it can address gaps in its R&D ecosystem and clinical infrastructure, it may even become a home for biotech innovators”, says the editorial

Continue reading

Unnatural selection, don’t stop at episode 1

I binge-watched Unnatural Selection, as many CRISPR enthusiasts have done. My review in a few words: the Netflix miniseries is a patchwork of bad and good. On the minus side, too many biohackers and too little real science. On the plus side, some interesting reporting on social issues, such as public engagement of local communities and the challenge of patient access to novel therapies. To sum up: episode 1 on biohacking is the worst, episode 3 on gene drives is the best. So my advice is: don’t give up at the first disappointing scenes. You might want to, but do not stop.

Crazy 4 Prime Editing

Great piece of science by the Liu Lab in Nature, describing the brand new “Search-and-replace genome editing without double-strand breaks or donor DNA”. How is the CRISPR community reacting?

Best quote: “One of those ‘Yay, science!!!’ kind of moments” (Fyodor Urnov quoted in Science)

Most ironic: “Congratulations @davidrliu. We’d probably have published this paper as well (The CRISPR Journal tweet)

Best title: Genome Editing Heads to Primetime (Genetic Engineering and Biotechnology News)

Most understated: A New Gene Editing Tool Could Make CRISPR More Precise (Smithsonian Mag)

Most hyped: A New CRISPR Technique Could Fix Almost All Genetic Diseases (Wired)

Born to kill. New CRISPR hope for fighting resistant bacteria

CRISPR evolved in bacteria as a defense mechanism against viral infections. But now researchers are turning the same weapon against bacteria themselves, hoping to defuse antibiotic resistance, which according to WHO is one of the biggest threats to global health.  

Continue reading